HomeGreater Than Icon
Mutual FundsGreater Than Icon
Compare Mutual FundsGreater Than Icon
HDFC ELSS Tax Saver Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

HDFC ELSS Tax Saver Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

stock1

HDFC ELSS Tax Saver Fund - Direct (G)

16.59%

stock2

Nippon India Pharma Fund - Direct (G)

18.23%

Graph not available
Graph not available

About Fund

HDFC Bank Limited & Citibank N.A

Computer Age Management Services Pvt. Ltd.

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Very High Risk

500

15555.71

1.84

1473.564

January 1, 2013

0

Very High Risk

5000

8080.97

1.12

554.7449

January 1, 2013

1

29.39 %

23.26 %

16.59 %

23.47 %

20.59 %

18.23 %

Amit Ganatra

M.Com., CA., CFA.,

Jan 2007 - till date Invesco Asset Management (India) Private Limited Jan 2006 - Dec 2006 Analyst - Equity - DBS Cholamandalam Asset Management Company Pvt. Ltd. Nov 2003 - Dec 2005 Sector Specialist - Equity Research - Fidelity Business Services India Pvt. Ltd. Apr 2003 - Oct 2003 Analyst - Centre For Monitoring Indian Economy - CMIE

Roshi Jain

Post Graduate Diploma in Management.CFA., ACA., CFA, PGDM, ACA

She is responsible for investment in foreign securities research (Since May 2005), identifying investment opportunities in capital goods, retail, textiles & transportation sector. Prior Goldman sachs, london (2004 - 2005) Responsible for equity Researched European building material stocks. - Goldman sachs, Singapore / HK (2002 - 2004). Responsible for equity research, researched Asian retail stocks. Wipro ltd. (1999 - 2000). Responsible for internal audit, Internal audit of processes & transactions. - S. R. Batliboi & Co. (1999). Responsible for statutory audit of corporate.

Vinay Kulkarni

B.Tech (IIT-Mumbai), PGDM (IIM-Bangalore)

Prior to joining HDFC Mutual Fund he has worked with Tata AMC, Deutsche Mutual Fund, UTI Mutual Fund and Patni Computer Systems Ltd.

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Get your FAQs right

When comparing HDFC ELSS Tax Saver Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G), consider factors such as historical performance, expense ratios, investment strategy, risk level, and the fund manager's credibility. Moreover, look at asset allocation and how each fund fits your investment goals.
Yes, you can invest in both HDFC ELSS Tax Saver Fund - Direct (G) and Nippon India Pharma Fund - Direct (G) at the same time. This can help diversify your portfolio and balance risk, provided the fund manager's investment strategies streamline each other.
While comparing HDFC ELSS Tax Saver Fund - Direct (G) and Nippon India Pharma Fund - Direct (G), the portfolio turnover ratio indicates how frequently assets within the fund are bought and sold. A high turnover may lead to higher transaction costs and tax implications, while a low turnover ratio indicates a buy-and-hold strategy.
Yes, you can typically switch between HDFC ELSS Tax Saver Fund - Direct (G) and Nippon India Pharma Fund - Direct (G), subject to the fund's policies and any applicable fees. It is important to consider potential tax implications and the timing of your switch.
Yes, you can compare HDFC ELSS Tax Saver Fund - Direct (G) and Nippon India Pharma Fund - Direct (G) based on their dividend payouts. Look at dividends profit, consistency, and growth, as these factors can influence your overall return on investment.

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions